Clinical Trial Update: Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery [Phase 4]

View source ↗

Summary

This Phase 4 dose-ranging trial evaluated ramosetron for prevention of postoperative nausea and vomiting following gynecologic laparoscopic surgery and has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Ramosetron (ramosetron)

Snippet

Sponsor: Yonsei University | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: COMPLETED